NEW YORK (GenomeWeb News) – MDS today announced that it expects to report 2008 revenue growth of between 12 percent and 16 percent.
The Toronto-based firm said its revenues for full-year 2008 should be between $1.35 billion and $1.4 billion, up from $1.2 billion in 2007.
MDS also said it expects to report adjusted EBITDA in the range of $175 million to $185 million and adjusted earnings per share of $.37 to $.43, compared with adjusted EBITDA of $145 million, or $.34 per share, in 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.